APA-Zitierstil (7. Ausg.)

Gökbuget, N., & Buß, E. C. (2014). BLAST: A confirmatory, single-arm, phase 2 study of blinatumomab, a bispecific T-Cell engager (BiTE (R)) antibody construct, in patients with minimal residual disease B-precursor acute lymphoblastic leukemia (ALL). Blood, 124(21), .

Chicago-Zitierstil (17. Ausg.)

Gökbuget, Nicola, und Eike Christian Buß. "BLAST: A Confirmatory, Single-arm, Phase 2 Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE (R)) Antibody Construct, in Patients with Minimal Residual Disease B-precursor Acute Lymphoblastic Leukemia (ALL)." Blood 124, no. 21 (2014).

MLA-Zitierstil (9. Ausg.)

Gökbuget, Nicola, und Eike Christian Buß. "BLAST: A Confirmatory, Single-arm, Phase 2 Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE (R)) Antibody Construct, in Patients with Minimal Residual Disease B-precursor Acute Lymphoblastic Leukemia (ALL)." Blood, vol. 124, no. 21, 2014.